In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Drug:  imiquimod
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 0559/07, NCT00803907
2.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09US05N375-Gold, NCT01203878
3.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10-0933, NCT01229319
4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GW01-1001, NCT01413763
5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: IPDTAKOTR/V06/28.12.11, NCT01538901
6.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Trial Photoderm Graz 2010-1, NCT01088737
7.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SYM 2012-01, NCT01686152
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Luc 10-002, NCT01191034
9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: ITIC2, NCT01283763
10.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NYU 11-00598, 1R01CA161891-01, NCT01421017
11.

Phase: Phase II
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: Eudract number: 2006-004902-16, LREC number: 06/Q2201/143, NCT00596336
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6578, NCI-2010-00040, R01CA138521, 131, UWCC-6578, FHCRC-6578, IR-6578, NCT00821964
13.

Phase: Phase II
Type: Prevention
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: _1.0, ISRCTN: 2008-004893-42, NCT00941811
14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-000202, NCT01204684
15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MM1120, NCT01543464
16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: JHOC-J0656, J0656, NA_00002176, NCT00788164
17.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: LU 1006 - IDO, NCT01219348
18.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: IMA950-102, 11C0192, NCT01403285
19.

Phase: Phase I
Type: Treatment
Status: Active
Age: 3 to 25
Sponsor: Other
Protocol IDs: 2009LS136, 1004M81213, NCT01400672
20.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 01 KI 0211, NCT00365729
21.

Phase: No phase specified
Type: Treatment
Status: Approved-not yet active
Age: 49 to 89
Sponsor: Other
Protocol IDs: WN07DE002, EudraCT No: 2007-001961-14, NCT00463359
22.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-347, NCT00865644
23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 15168, NCT01264731
24.

Phase: No phase specified
Type: Diagnostic, Health services research, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 23592103, NCT01663558
25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-136, NCT01678352
New Search